Practical advice on eradicating Helicobacter pylori infection

Postgraduate Medicine
D Y GrahamJ E Scherger

Abstract

Peptic ulcer disease associated with H pylori infection is curable. The important factors in selecting therapy are efficacy of eradication, prevention of resistance, avoidance or minimization of adverse effects, patient compliance, and cost. The most effective regimens include a bismuth preparation or antisecretory drug (proton pump inhibitor or H2 receptor antagonist) plus two antibiotics administered for 14 days. Dual-drug therapies are not recommended. Triple-drug regimens are more likely to eradicate H pylori and less likely to generate resistant strains among surviving organisms. In general, cure of the infection should be confirmed 4 weeks after completion of the treatment. Antibiotic resistance is an important consideration in choosing therapy, and patients should be taught the importance of compliance. When treatment fails, antibiotic combinations should not be repeated. Considerations for anti-H pylori treatment in a managed care environment mirror those for good medical practice in general, with special attention to stringent cost-control or outcomes-driven measures.

References

Aug 15, 1995·Annals of Internal Medicine·A M FendrickB S Bloom
Oct 12, 1995·The New England Journal of Medicine·J H Walsh, W L Peterson
May 8, 1995·Archives of Internal Medicine·A Sonnenberg, W F Townsend
Jan 19, 1995·The New England Journal of Medicine·J J SungA K Li
Feb 7, 1994·NIH Consensus Statement
May 20, 1996·The American Journal of Medicine·R H Hunt
May 20, 1996·The American Journal of Medicine·N Vakil, B Fennerty
Mar 1, 1996·Helicobacter·R W van der HulstG N Tytgat
Jan 1, 1997·International Journal of Antimicrobial Agents·S Miehlke, D Y Graham

Citations

Jul 20, 2010·Annals of Diagnostic Pathology·Xiaohong I WangJaiyeola Thomas
Jan 30, 2004·Fundamental & Clinical Pharmacology·Bülent Sivri
Mar 15, 2002·Applied Immunohistochemistry & Molecular Morphology : AIMM·Nirag JhalaMamoun Younes

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
A R WebsterE R Maher
Helicobacter
Takahisa Furuta, Jean-Charles Delchier
International Journal of Antimicrobial Agents
S Miehlke, D Y Graham
Indian Journal of Pediatrics
U BleckerB D Gold
Scandinavian Journal of Gastroenterology. Supplement
R H Hunt, A H Mohamed
© 2021 Meta ULC. All rights reserved